SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (9993)10/23/2008 8:25:08 PM
From: IRWIN JAMES FRANKEL2 Recommendations  Read Replies (1) | Respond to of 10345
 
>>I wouldn't give Campath to a sick dog...

I had not read that it helped sick dogs*. :-)

But a 74% reduction in exacerbations relative to Rebif sounds promising for RRMS.

Am I right that it is the side effects that make Campath unsuitable for RRMS?

ij

* Might even help EAE mice.



To: zeta1961 who wrote (9993)10/24/2008 9:30:00 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 10345
 
:-)

I presume that "some" means "some GENZ"?

Best! Rick

(I.J.... yes, it's hard to have autoimmunity, without the "immunity" part.)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News